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Traumatic brain injury (TBI) is a major cause of death and permanent disability. Systemic hypo-
thermia, a treatment used in TBI for many decades, has recently been found to be associated
with neutral or unfavourable clinical outcomes despite apparently promising preclinical
research. Systematic review and meta-analysis is a tool to summarize literature and observe
trends in experimental design and quality that underpin its general conclusions. Here we aim to
use these techniques to describe the use of hypothermia in animal TBI models, collating data
relating to outcome and both study design and quality. From here we intend to observe corre-
lations between features and attempt to explain any discrepancies found between animal and
clinical data. This protocol describes the relevant methodology in detail.
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1 | BACKGROUND
Traumatic brain injury (TBI) represents a significant challenge in
healthcare across the world: it is the leading cause of death and per-
manent disability in young adults and incidence is increasing.2,3
Despite significant progress in the understanding of pathophysiology
and developments of novel experimental treatments, there have been
no consequential therapies successfully translated into clinical prac-
tice. Similarly, many of the treatments accepted as standard care have
weak evidence bases.4–7
Hypothermia is a therapy well established in the neuro-intensive
care, having been commonplace in TBI management for half a
century. It is based on the underlying principle that hypothermia con-
trols dangerously elevated intracranial pressure and mediates damage
to neural tissue from hypoxic and other metabolic mechanisms. How-
ever there is increasing evidence that, in TBI patients, induced hypo-
thermia is at least as effective at controlling intracranial pressure as
This protocol is based on the Systematic Review Protocol for Animal Interven-
tion Studies (Table 1).1
TABLE 1 Progress at time of protocol submission
Stage of process Started Completed
Preliminary searches Yes Yes
Piloting study selection Yes No
Formal screening with final search criteria No No
Data extraction from included papers No No
Quality assessment No No
Data analysis No No
Manuscript writing No No
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other medical therapies, however, importantly it is associated with
neutral or unfavourable long term outcomes.4,8,9
These findings contradict a consensus that hypothermia in in vivo
studies is effective. We therefore seek to describe the preclinical litera-
ture using systematic review and meta-analysis, and aim to provide an
explanation as to why this discrepancy might exist. We hypothesize
that the preclinical dataset will consist of a large number of small, het-
erogeneous studies with differences in efficacy associated with fea-
tures relating to both risk of bias (randomization, blinding, publication
bias) as well as experimental design features (features of animals used,
TBI model, hypothermia treatment and control group temperature).
2 | METHODS
2.1 | Literature search
We will search PubMed, MEDLINE and EMBASE using the search
strategies below:
(traumatic brain injury OR TBI OR head injury OR head trauma
OR brain trauma OR neurotrauma OR cortical trauma OR cerebral
trauma OR weight drop OR fluid percussion OR controlled cortical
impact OR projectile concussive impact OR blast-induced neuro-
trauma) AND (hypotherm* OR normotherm* OR temperature OR
thermoregulat* OR cool* OR cold OR chill OR cryo*)
Searches will be limited to animals using previously developed
filters.10,11
2.2 | Study selection
We will include studies that satisfy the following inclusion criteria:
1. Animal model, non-neonatal
2. Non-penetrating traumatic brain injury model
3. Systemic hypothermia used as monotherapy
4. Compared to normothermic or hyperthermic control in same study
5. Mean / Median value, variation (SE, SD, CI) and the number of ani-
mals stated for each group
6. All outcomes relating to neurobehavioural assessment, ICP, contu-
sion size, mortality, biochemical or histological markers of neuronal
cell death, axonal damage, oedema
We will first screen titles and abstracts, excluding studies not
relating to an animal model of TBI. Subsequently we will screen full
articles of remaining studies and apply the above selection criteria.
Two authors will screen studies (TCH/RW) and differences will be
resolved by discussion. In cases of no consensus and third reviewer
(MRM) will be consulted.
There will be no language or date restrictions and all peer review
articles, conference abstracts and other modalities of publication will
be accepted if sufficient information is provided for inclusion.
Reviews and clinical papers will be excluded.
2.3 | Methodological quality and study bias
We will assess risk of bias according to a modified scale developed
by the CAMARADES group for stroke studies:12
1. Peer reviewed journal
2. Randomized group allocation with method stated
3. Blinded induction of injury
4. Blinded assessment of outcome
5. Sample size calculation
6. Statement of potential conflict of interest
7. Animal welfare policy stated
8. Use of anaesthetic agent without intrinsic neuroprotective prop-
erty (ketamine)
9. Reporting of total number of animals treated
10. Explanation of excluded animals
2.4 | Data extraction
We will use neurobehavioural outcome scores as our primary
outcome.
Secondary outcome measures: we will include pathological indi-
cators such as contusion/haematoma size, physiological measure-
ments such as intracranial pressure and biochemical markers of
oedema, cell death or axonal damage.
We will include all studies comparing a hypothermic treatment
group (induced or permissive) with a normothermic or hyperthermic
control (induced or natural disease course). For studies reporting
more than one group we will include all comparisons, correcting for
the number of control groups as appropriate.
Relating to study design, we will extract the information outlined
in Table 2.
2.5 | Data collation and analysis
Data will be extracted in duplicate by TCH and RW. Differences in
extracted data will be resolved by discussion. We will extract data
from publications via text, if available, or by measurement from
graphs with a digital screen ruler. Should this information not be
immediately clear from the publication we will contact the authors
directly. We will correct for the multiple use of a single control group
by dividing the number of animals in each control group by the num-
ber of times represented in the dataset.
For neurobehavioural outcomes, we will pool data for analysis
using the DerSimonian and Laird random-effects model, as we expect
a large degree of methodological variability between studies, and
assess for the presence of heterogeneity using the I2 statistic. We will
then attempt a multi-variable metaregression to investigate relation-
ships between reported efficacy and the study quality and design fea-
tures highlighted above, for variables in which there are 10 studies or
more in every group. In sensitivity analysis, we will perform a univari-
ate metaregression.
For secondary outcomes, namely contusion size, ICP, mortality
and biochemical markers we intend to first perform a frequency anal-
ysis to describe the number of times each outcome or molecule is
reported in the literature. Following this, we will calculate efficacy
estimates (via a random-effects model) for those outcomes with
10 or more included experiments. We have set this threshold as this
is a level at which we deem there to be enough data to warrant colla-
tion for meta-analysis.
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We will search for publication bias using funnel plots, Egger
regression and p-curve analysis.13
Changes in this analysis plan will be announced and reported in
the study publication subsequently.
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TABLE 2 Study design characteristics to be extracted
Study identifiers 1. Author
2. Year of publication
3. Journal





TBI paradigm 1. Injury model type (weight drop, fluid percussion, controlled cortical injury, projectile concussive impact, penetrating
ballistic-like brain injury, blast-induced neurotrauma)
2. Cranium unopened/craniotomy/craniectomy
3. Location of injury (lobe)
4. Impactor velocity/peak pressure wave
5. Baseline neurobehavioural score
6. Method of animal head stabilization
7. Anaesthetic agent
8. Anaesthesia duration
Hypothermia 1. Target temperature
2. Duration of hypothermia
3. Method of hypothermia induction (intra/extracorporeal, permissive)
4. Delay to treatment
5. Rate of rewarming
6. Method of rewarming
7. Control group temperature 1) normothermia (36.0-37.9C for mammals) or 2) hyperthermia (≥38.0C)
8. Control group temperature induced or passive
Primary outcome
measure
1. Neurobehavioural outcome score
Secondary outcome
measures
1. Change in contusion size
2. ICP
3. Mortality
4. Biochemical or histological markers: oedema (eg AQP4), axonal damage (e.g. APP), neural cell death
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